Pfizer CEO says new vaccine against Omicron variant will be available in March

According to Pfizer’s CEO, a Covid-19 vaccine targeting the Omicron variant is to be available in March.

Pfizer CEO Albert Bourla told CNBC that the company is already producing dosages in response to government demand, as authorities deal with high Covid-19 infection rates, including large numbers of “breakthrough” Omicron infections in vaccinated populations.

Bourla told the network, “This vaccination will be ready in March.” “I’m not sure if we’ll need it. I’m not sure if or how it’ll be used.”

- Advertisement -

According to Bourla, the current vaccination regimen of two doses and a booster has provided “reasonable” protection against Omicron’s adverse health consequences.

However, a vaccination targeting the Omicron variation would protect against outbreaks of a strain that has proven extremely infectious while also causing many mild or asymptomatic illnesses.

Moderna CEO Stephane Bancel said in a separate interview with CNBC Monday that the company is working on a booster that might combat Omicron and other new strains in the fall of 2022.

“We’re talking to public health authorities all around the world to figure out what the best strategy is for a possible booster in the fall of 2022,” Bancel told the network.

- Advertisement -

“We need to be careful to try to stay ahead of a virus and not behind the virus.”


Follow Us On

- Advertisment -


EFCC operatives storm Okorocha’s Abuja residence to arrest him

The Economic and Financial Crimes Commission (EFCC) raided Rochas...

Watch the Final Trailer for StrangerThings 4 Volume 1 – Streaming This Friday on Netflix

The last Stranger Things 4 trailer emerged, and it's...

Nicky Oppenheimer beats Johann Rupert to become the richest person in South Africa

Johann Rupert, the founder of Swiss luxury goods conglomerate...